Overview
Gregory Mathez practices practicing medicine in Lausanne, Switzerland.
His clinical expertise encompasses Severe Acute Respiratory Syndrome (SARS), Parainfluenza Virus Type 3, and Flu.
He is actively involved in clinical research, co-authoring 15 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Gregory Mathez
Is Gregory Mathez a top-rated expert for Severe Acute Respiratory Syndrome (SARS)?
MediFind is an objective health platform that identifies experts based on real-world data. Gregory Mathez is classified as an Experienced expert for Severe Acute Respiratory Syndrome (SARS), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Gregory Mathez participate in research or clinical trials?
Yes. Gregory Mathez has published 15 articles and abstracts on conditions like Severe Acute Respiratory Syndrome (SARS). You can view a list of Gregory Mathez's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- FluMr. Mathez isExperienced. Learn about Flu.
- Parainfluenza Virus Type 3Mr. Mathez isExperienced. Learn about Parainfluenza Virus Type 3.
- Severe Acute Respiratory Syndrome (SARS)